It has been shown that long noncoding RNAs (lncRNAs) are involved in the carcinogenesis of multiple cancers. However, the roles of lncRNAs in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) remain elusive. In the present study, we found that lncNEN885 was markedly decreased in human gas- 
metastasis, especially liver metastasis, is as common as other carcinomas, which results in more difficult treatment and worse prognosis. 3, 4 Thus, seeking sensitive and distinctive biomarkers for early diagnosis of metastasis is a key method toward the effective treatment of GEP-NEN patients.
Long noncoding RNAs (lncRNAs), known as RNAs longer than 200 nt without translated protein products, are vital regulators involved in tumor initiation, progression, and metastasis. 5, 6 Previous studies have reported that dysregulated expression of lncRNAs is frequently relevant to tumorigenesis and metastasis as well as novel effective biomarkers for prognosis in other carcinomas. For instance, lncTCF7 regulated transcription factor 7 expression and induced activation of Wnt signaling in human liver cancer stem cells. 7 LncRNA-ATB could foresee metastasis in hepatocellular carcinoma patients and serves as a potential target for antimetastatic therapies. 8 However, there is only one published report relating to lncRNAs and GEP-NENs, which identified a tumor growth and metastasis suppressive modulator named lncMEG3 in pancreatic neuroendocrine tumors. 9 Therefore, more potentially effective lncRNAs for early diagnosis of metastasis in GEP-NEN patients need to be explored.
Epithelial-mesenchymal transition (EMT) has been known as an important modulator in the tumorigenic process, especially metastasis. 10 It has been first described in embryonic development, inducing the transition of epithelial cells to cells with a mesenchymal phenotype. Some prototypical markers, such as Snail, E-cadherin, and vimentin, are defined as characteristic of EMT. [11] [12] [13] [14] Epithelialmesenchymal transition is associated with an invasive or metastatic phenotype of several tumors, including colorectal cancer and gastric cancer. 15, 16 Wnt/β-catenin signaling, which functions as a mediator to maintain epithelial cell phenotype, proper cell-cell junctions, and tissue homeostasis, is involved in the development of cancer and EMT-related metastasis. 17, 18 However, the role of EMT and its mechanism in GEP-NENs have not been elucidated until now.
In our study, we found a novel lncRNA (Enst00000414885) named lncNEN885 in human gastric neuroendocrine neoplasms by transcriptome sequencing. LncNEN885 was markedly decreased in human gastric neuroendocrine neoplasm samples compared to adjacent normal tissues. Dysregulation of LncNEN885 did not obviously affect cellular proliferation and apoptosis but did influence cell migration, invasion, and wound-healing rates in BON-1 and LCC-18 cells by activating EMT partially through canonical Wnt/β-catenin signaling. LncNEN885 is a potentially novel biomarker for the metastasis of GEP-NENs.
| MATERIALS AND METHOD

| Patients and samples
The GEP-NEN tissues and adjacent normal gastric tissues were obtained from three patients who underwent surgical resection at the First Affiliated Hospital of Nanjing Medical University (Nanjing, China). None of the patients received any local or systemic treatment before surgery. All experiments were approved by the Research Ethics Committee of Nanjing Medical University. Written informed consent was obtained from all participants.
| Gene expression profiles
Total RNA was extracted and purified according to the protocol described elsewhere. cDNA was prepared according to the standard Affymetrix protocol from 250 ng total RNA by using GeneChip (Genminix Informatics Ltd. Co., Shanghai, China) WT PLUS Reagent.
The differentially expressed lncRNAs with statistical significance were identified with volcano plot filtering. The threshold we used to screen upregulated or downregulated lncRNAs is fold change >2 and P-value < .05. 
| Cell culture
| Protein extraction and western blotting
The method for protein from cells and tissues was extracted according to the manufacturer's recommended protocol (Vazyme, Nanjing, China). Samples from cell lysates were resolved by SDS-PAGE and then transferred to PVDF membranes and incubated with specific antibodies (Cell Signaling Technology, Boston, MA, USA). The ECL chromogenic substrate was used to detect specific bands. Actin and GAPDH were used as the inner control. Relative protein levels were quantified by ImageJ (https://imagej.nih.gov/ij/).
All antibodies were purchased from Abcam (Cambridge, MA, USA).
(ab131372), adenomatous polyposis coli (APC) (ab15270), Actin (ab8224), and GAPDH (ab8245). 
| Flow cytometry
| Apoptosis assays
Apoptotic assays were carried out with one-step TUNEL (Beyotime Institute of Biotechnology) reactions. Briefly, the samples (tissues and pretreated cells) were permeabilized with 0.1% Triton X-100 for 2 minutes at 4°C, and the TUNEL complex was added for 1 hour at 37°C.
Hoechst 33342 (Beyotime Institute of Biotechnology) was used to label nuclei. The TUNEL-positive cells were imaged with a microscope. The cells with deep green fluorescence were defined as apoptotic cells.
| Cell proliferation assay
Cell proliferation was assessed by CCK-8 assay (Beyotime Institute of Biotechnology). Cells were trypsinized and plated at a density of 2000 cells/100 μL medium per well in 96-well culture plates. At different time points after transfection, 10 μL CCK-8 liquid was added to wells and further incubated for 1 hour at 37°C.
The absorbance was measured at 450 nm.
| Cell migration, invasion, and wound-healing assays
At 24 hours after transfection, the cells in serum-free media were seeded into the upper chamber for migration assays (8-μm pore size;
Millipore, Darmstadt, Germany) and invasion assays with the Matrigel-coated (BD, Franklin Lakes, NJ, USA) filters in 24-well plates following the protocol described elsewhere.
For wound-healing assays, cells transfected with Lv-lncNEN885 or si-lncNEN885 were cultured in 12-well plates to approximately 90% confluence, and the monolayer was wounded using a vitreous pin that delivered a precise scratch. Images of the extent of wound healing were captured at 0, 24, 48, 72 hours.
| Statistical analysis
All the experiments were carried out at least three times independently, each in triplicate. Bars represented mean ± SEM. Significance tests were analyzed by Student's t test using SPSS software (IBM SPSS 20.0, Chicago, IL, USA), and a P-value < .05 was considered significant.
| RESULTS
| LncNEN885 expression pattern in tissues and dysregulation of LncNEN885
To examine whether lncRNA variation was involved in GEP-NEN progression and metastasis, we explored the expression profiles of lncRNAs in GEP-NENs and normal neighboring noncancerous tissues using gene chip analysis. The lncRNAs with a fold change >2 and P-value < .05 in gene chip data were selected. We found 13 upreg- 
| Dysregulation of LncNEN885 did not influence cell apoptosis
In view of the effect of lncNEN885 on the growth of cancers, we still considered that dysregulation of lncNEN885 could affect cell Figure 3A ,B) and TUNEL assay ( Figure 3C,D) . The results showed that Lv-lncNEN885 or silncNEN885 treatment did not significantly affect cell apoptosis compared to the control group. Therefore, we concluded that dysregulation had no effect on cell proliferation or apoptosis in GEPNENs. , and 72 h after transfection. **P < .01, ***P < .001
| Dysregulation of LncNEN885 mediated cell migration, invasion, and wound-healing rate
and western blot assays were undertaken to examine the levels of EMT. As shown in Figure 7 , we found that after transfection with si-β-catenin, the expressions of N-cadherin and vimentin were observed to be significantly downregulated, whereas the expression of E-cadherin was obviously upregulated. Furthermore, cotransfection with si-catenin and Lv-lncNEN885 could enhance this phenomenon, and si-lncNEN885 could reverse the effect of β-catenin on the expression of EMT. These results showed that dysregulation of lncNEN885-related EMT partially relied on Wnt/β-catenin signaling.
| DISCUSSION
In recent years, lncRNAs have been a hot point in the research of developmental processes and disease states as a potentially novel and crucial layer of biological regulation. 19 Several studies have reported that dysregulation of lncRNAs might induce multiple diseases, such as diabetes, kidney dysfunction, cardiovascular diseases, and malignant tumors. [20] [21] [22] [23] The role of lncRNAs in cancer has been the focus of this research. 24 However, little is known about the role of lncRNAs in GEP-NENs.
In the present study, we aimed to search anomalous lncRNAs in GEP-NEN patients for early diagnosis and therapeutic targets.
With transcriptome sequencing analysis, we found that the level of lncNEN885 was downregulated in human gastric neuroendocrine neoplasm tissues. LncNEN885 is a 567-bp lncRNA that is expressed at low levels in cancer tissues. However, there have been no published reports into lncNEN885 and human disease until now. Cancer is often considered a disease of deregulated cell proliferation and apoptosis. 25 Thus, we explored the role of lncNEN885 in GEP-NENs. Regrettably, silencing or overexpression of lncNEN885 showed no significant effect on cellular proliferation or apoptosis in BON-1 or LCC-18 cells. We concluded that dysregulation of lncNEN885 might not affect cell death or growth in GEP-NENs. In view of the metastatic features of GEP-NENs, especially the liver metastasis, 26 we detected the influence of lncNEN885 on metastatic ability and found that overexpression of lncNEN885 could inhibit cellular migration and invasion in BON-1 and LCC-18 cells. Moreover, overexpression of lncNEN885 could inhibit the healing rate, but silencing of lncNEN885 could promote the healing rate.
We concluded that dysregulation of lncNEN885 could affect the metastasis of GEP-NENs. We then wondered how lncNEN885 variation affected metastasis. Previous studies have suggested that EMT contributes to dissemination of cancer cells and is pivotal for invasion and metastasis. 27, 28 The assay on the level of EMT-related protein revealed that high levels of lncNEN885 could increase the expression of Snail, vimentin, and N-cadherin and decrease E-cadherin levels. Thus, we believed that dysregulation of lncNEN885 could mediate metastasis by activating EMT in GEPNENs.
The canonical Wnt/β-catenin pathway is a family of extracellular signaling that can influence cellular differentiation, division, and survival in several cancers and other diseases. [29] [30] [31] [32] A named "destruction complex" composed of β-catenin, APC, Axin, casein kinase 1, and GSK3β proteins often results in the phosphorylation, polyubiquitination, and proteasomal degradation of β-catenin in the absence of Wnt ligand. 33 Phosphorylation of GSK3β can break this complex and inhibit its ability to phosphorylate β-catenin, which initiates several cellular behaviors such as EMT. [34] [35] [36] In our study, we found that silencing of lncNEN885 could dramatically increase the 
